# Program 1 Phase E Closure Report

Status: closed

## E0-E20 Summary

Phase E defined review workflow foundation, review boundaries, source-linking, human responsibility, decision and recommendation separation, audit and permission contracts, UI wording, passive review schemas, safety tests, no-go matrices, CI expectations and production blockers.

## Runtime Behavior Changed

No runtime behavior changed.

## Docs Added

E0-E20 documentation now defines review semantics without approving runtime workflow.

## Schema/Test Changes

Passive review schemas and `test_clinical_review_contract.py` were added.

## Safety Properties Preserved

No review endpoint, DB model, migration, service, UI, Task, Outcome Evidence, patient messaging, diagnosis/treatment automation, approval, clearance, override, appointment status mutation, production approval or real-data approval.

## Final Recommendation

Proceed to Program 1 Phase F0 - Clinical Evidence Timeline Integration Foundation, documentation-only.
